Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

J&J has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating plaque ...

Alzheon's Alzheimer's drug showed nominal benefit in a subgroup of patients who suffer with mild cognitive impairment.

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Oculis has concluded subject enrolment for the Phase III clinical trials of OCS-01 eye drops for diabetic macular oedema.

One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

April is dedicated to raising awareness of Parkinson’s disease to support individuals suffering from the condition and those ...

Breaking Science Session at the 2025 American Academy of Neurology (AAN) meeting, Remegen announced exciting results from a Phase III clinical trial evaluating the efficacy and safety of telitacicept.

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

Amylyx Pharmaceuticals has dosed the first subject in the Phase I LUMINA trial, investigating AMX0114, a potential treatment ...

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...